The MIT spinout has developed semiconductor technology that uses light rather than electrical signals to process data.

Spun out from Memorial Sloan Kettering Cancer Center, Paige.ai is developing artificial intelligence technology to improve the clinical diagnosis and treatment of cancer.

Two government-backed vehicles have invested in Manchester Imaging, which will soon launch software to detect early signs of tooth decay.

Future Planet Capital is set to receive up to $200m in capital from TW & Partners for its inaugural fund.

The vehicle, which has already secured $470m in commitments, will aim to help commercialise British research and help companies expand into China.

The spinout is building drug discovery technology that uses artificial intelligence and machine learning to identify biomarkers, drug targets and pathways.

The University of Waterloo spinout has been backed by university-linked investors as it prepares to expand its range of biosensor nanotechnology products.